首页 > 最新文献

Chinese journal of otorhinolaryngology head and neck surgery最新文献

英文 中文
[Exploration of inflammatory spatial pathology of nasal polyps]. 鼻息肉炎性空间病理探讨。
Q4 Medicine Pub Date : 2025-12-07 DOI: 10.3760/cma.j.cn115330-20250701-00346
Z X Hua, X Luo, Q T Yang
{"title":"[Exploration of inflammatory spatial pathology of nasal polyps].","authors":"Z X Hua, X Luo, Q T Yang","doi":"10.3760/cma.j.cn115330-20250701-00346","DOIUrl":"10.3760/cma.j.cn115330-20250701-00346","url":null,"abstract":"","PeriodicalId":23987,"journal":{"name":"Chinese journal of otorhinolaryngology head and neck surgery","volume":"60 ","pages":"1489-1495"},"PeriodicalIF":0.0,"publicationDate":"2025-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145725625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Robots and embodied intelligence in endoscopic transnasal surgery: advances, challenges, and future perspectives]. [内窥镜鼻手术中的机器人和具身智能:进展、挑战和未来展望]。
Q4 Medicine Pub Date : 2025-12-07 DOI: 10.3760/cma.j.cn115330-20250819-00438
Z H Shi, F X Zhong
{"title":"[Robots and embodied intelligence in endoscopic transnasal surgery: advances, challenges, and future perspectives].","authors":"Z H Shi, F X Zhong","doi":"10.3760/cma.j.cn115330-20250819-00438","DOIUrl":"10.3760/cma.j.cn115330-20250819-00438","url":null,"abstract":"","PeriodicalId":23987,"journal":{"name":"Chinese journal of otorhinolaryngology head and neck surgery","volume":"60 ","pages":"1624-1629"},"PeriodicalIF":0.0,"publicationDate":"2025-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145726124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Frequency characteristics of utricular damage and pathological ultrastructural analysis in patients with unilateral Ménière's disease]. [单侧m懊悔病患者心室损伤的频率特征及病理超微结构分析]。
Q4 Medicine Pub Date : 2025-12-07 DOI: 10.3760/cma.j.cn115330-20250307-00129
Y L Chen, Y L Li, X F Li, Y D Song, Y F Lyu, N Li, D G Zhang

Objective: To investigate the frequency characteristics of utricular damage and pathological ultrastructural features in patients with unilateral Ménière's disease (MD). Methods: This cross-sectional study included 104 patients with unilateral MD admitted to Shandong Provincial ENT Hospital between July 2019 and September 2021. There were 50 males and 54 females, aged 21-72 years (mean 46.4 years). Disease duration ranged from 1 month to 40 years (median duration 4.5 years). All patients underwent pure-tone audiometry and vestibular function tests, including caloric test, video head impulse test (v-HIT), vestibular evoked myogenic potentials (VEMP), and unilateral centrifugation subjective visual vertical (UC-SVV). Utricular maculae from 4 patients who underwent labyrinthectomy for intractable vertigo were observed under light microscopy and transmission electron microscopy (TEM). Type Ⅰ and Type Ⅱ hair cells were counted and compared, and common pathological changes of the utricular macula were observed. SPSS 19.0 software was used for statistical analysis. Results: According to pure-tone average, patients were clinically staged as follows: stage Ⅰ, 26 cases; stage Ⅱ, 26 cases; stage Ⅲ, 39 cases; and stage Ⅳ, 13 cases. The abnormality rates of vestibular function tests were as follows: 63.5% by caloric test (66/104), 32.7% by v-HIT (34/104), 65.4% by cervical VEMP (cVEMP) (68/104), 68.3% by ocular VEMP (oVEMP) (71/104), and 58.7% by UC-SVV (61/104). There was a statistically significant difference in the abnormality rates between the caloric test and v-HIT, which assessed low-frequency and high-frequency semicircular canal function, respectively (χ²=7.775, P=0.005). However, there was no statistically significant difference in the abnormality rates between oVEMP and UC-SVV, which assessed high-frequency and low-frequency utricular function, respectively (χ²=0.495, P=0.482). Pathological examination under light microscopy revealed monolayer degeneration of the sensory epithelium in the utricular macula, with varying degrees of reduction in the number of both Type Ⅰ and Type Ⅱ hair cells and absence of cilia. No significant difference was observed in the quantity between Type Ⅰ and Type Ⅱ hair cells. TEM examination showed numerous vacuoles formed by swollen endoplasmic reticulum in the hair cells, dilated perinuclear cisternae, edema, scattered lipid droplets, and lysosome distribution within the cells. Occasional mitochondrial swelling was also observed. Conclusions: No frequency-specific characteristics were found in the oVEMP and UC-SVV test results of patients with unilateral MD. Damage was commonly observed in both Type Ⅰ and Type Ⅱ hair cells of the utricular macula, with no significant differences noted in cell count or the degree of damage between the two types.

目的:探讨单侧membroinitre病(MD)患者心室损伤的频率特征及病理超微结构特征。方法:本横断面研究纳入了2019年7月至2021年9月在山东省耳鼻喉科医院住院的104例单侧MD患者。男性50例,女性54例,年龄21 ~ 72岁,平均46.4岁。病程1个月至40年(中位病程4.5年)。所有患者均行纯音听力学和前庭功能测试,包括热量测试、视频头脉冲测试(v-HIT)、前庭诱发肌电位(VEMP)和单侧离心主观视觉垂直(UC-SVV)。本文在光镜和透射电镜下观察了4例迷路切除术后顽固性眩晕患者的视网膜黄斑。对Ⅰ型和Ⅱ型毛细胞进行计数比较,观察黄斑室常见的病理变化。采用SPSS 19.0软件进行统计分析。结果:按纯音平均,患者临床分期如下:Ⅰ期26例;分期Ⅱ,26例;Ⅲ期39例;Ⅳ阶段,13例。前叶功能检查异常率依次为:热量检查63.5%(66/104)、v-HIT检查32.7%(34/104)、颈VEMP检查65.4%(68/104)、眼VEMP检查68.3%(71/104)、UC-SVV检查58.7%(61/104)。热量试验与评估低频和高频半规管功能的v-HIT的异常率差异有统计学意义(χ 2 =7.775, P=0.005)。oVEMP与UC-SVV分别评估高频和低频心室功能的异常率差异无统计学意义(χ²=0.495,P=0.482)。光镜下病理检查显示室状黄斑感觉上皮单层变性,Ⅰ型和Ⅱ型毛细胞数量不同程度减少,纤毛缺失。Ⅰ型和Ⅱ型毛细胞数量无显著差异。透射电镜检查显示毛细胞内质网肿胀形成大量空泡,核周池扩张,水肿,脂滴分散,细胞内溶酶体分布。偶见线粒体肿胀。结论:单侧MD患者的oVEMP和UC-SVV检测结果未发现频率特异性。Ⅰ型和Ⅱ型毛细胞均存在损伤,两种类型在细胞计数和损伤程度上无显著差异。
{"title":"[Frequency characteristics of utricular damage and pathological ultrastructural analysis in patients with unilateral Ménière's disease].","authors":"Y L Chen, Y L Li, X F Li, Y D Song, Y F Lyu, N Li, D G Zhang","doi":"10.3760/cma.j.cn115330-20250307-00129","DOIUrl":"https://doi.org/10.3760/cma.j.cn115330-20250307-00129","url":null,"abstract":"<p><p><b>Objective:</b> To investigate the frequency characteristics of utricular damage and pathological ultrastructural features in patients with unilateral Ménière's disease (MD). <b>Methods:</b> This cross-sectional study included 104 patients with unilateral MD admitted to Shandong Provincial ENT Hospital between July 2019 and September 2021. There were 50 males and 54 females, aged 21-72 years (mean 46.4 years). Disease duration ranged from 1 month to 40 years (median duration 4.5 years). All patients underwent pure-tone audiometry and vestibular function tests, including caloric test, video head impulse test (v-HIT), vestibular evoked myogenic potentials (VEMP), and unilateral centrifugation subjective visual vertical (UC-SVV). Utricular maculae from 4 patients who underwent labyrinthectomy for intractable vertigo were observed under light microscopy and transmission electron microscopy (TEM). Type Ⅰ and Type Ⅱ hair cells were counted and compared, and common pathological changes of the utricular macula were observed. SPSS 19.0 software was used for statistical analysis. <b>Results:</b> According to pure-tone average, patients were clinically staged as follows: stage Ⅰ, 26 cases; stage Ⅱ, 26 cases; stage Ⅲ, 39 cases; and stage Ⅳ, 13 cases. The abnormality rates of vestibular function tests were as follows: 63.5% by caloric test (66/104), 32.7% by v-HIT (34/104), 65.4% by cervical VEMP (cVEMP) (68/104), 68.3% by ocular VEMP (oVEMP) (71/104), and 58.7% by UC-SVV (61/104). There was a statistically significant difference in the abnormality rates between the caloric test and v-HIT, which assessed low-frequency and high-frequency semicircular canal function, respectively (<i>χ</i>²=7.775, <i>P</i>=0.005). However, there was no statistically significant difference in the abnormality rates between oVEMP and UC-SVV, which assessed high-frequency and low-frequency utricular function, respectively (<i>χ</i>²=0.495, <i>P</i>=0.482). Pathological examination under light microscopy revealed monolayer degeneration of the sensory epithelium in the utricular macula, with varying degrees of reduction in the number of both Type Ⅰ and Type Ⅱ hair cells and absence of cilia. No significant difference was observed in the quantity between Type Ⅰ and Type Ⅱ hair cells. TEM examination showed numerous vacuoles formed by swollen endoplasmic reticulum in the hair cells, dilated perinuclear cisternae, edema, scattered lipid droplets, and lysosome distribution within the cells. Occasional mitochondrial swelling was also observed. <b>Conclusions:</b> No frequency-specific characteristics were found in the oVEMP and UC-SVV test results of patients with unilateral MD. Damage was commonly observed in both Type Ⅰ and Type Ⅱ hair cells of the utricular macula, with no significant differences noted in cell count or the degree of damage between the two types.</p>","PeriodicalId":23987,"journal":{"name":"Chinese journal of otorhinolaryngology head and neck surgery","volume":"60 12","pages":"1580-1585"},"PeriodicalIF":0.0,"publicationDate":"2025-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145811540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical study on induction chemotherapy combined with concurrent chemoradiotherapy for oropharyngeal squamous cell carcinoma]. 【诱导化疗联合同步放化疗治疗口咽鳞癌的临床研究】。
Q4 Medicine Pub Date : 2025-12-07 DOI: 10.3760/cma.j.cn115330-20250123-00069
J Wei, K Liu, N X Chen, J S Sui, T Sun, L Ma, X X Zhang

Objective: To investigate the efficacy and safety of non-surgical comprehensive treatment methods for patients with locally advanced oropharyngeal squamous cell carcinoma (OPSCC) and to analyze the impact of HPV (human papilloma virus) status on the patients' prognoses. Methods: A retrospective analysis was conducted on 152 patients with advanced OPSCC treated with non-surgical comprehensive treatment methods at the Department of Otolaryngology Head and Neck Surgery of the PLA General Hospital from October 2010 to October 2024. There were 114 males and 38 females, aged from 38 to 70 years, with a median age of 55.5 years. The treatments included induction chemotherapy (IC)+concurrent chemoradiotherapy (CCRT)±epidermal growth factor receptor (EGFR) molecular targeted therapy, including 126 patients treated with EGFR molecular targeted drugs during CCRT (124 with nimotuzumab+2 with cetuximab) and 32 patients with PD-1 immunotherapy during induction chemotherapy. Helical tomotherapy (HT) and intensity-modulated radiotherapy (IMRT) techniques were used in radiotherapy. The adverse reactions of chemoradiotherapy were assessed using the Common Terminology Criteria for Adverse Events (CTCAE) version 5. survival rates were analyzed using the Kaplan-Meier method and Cox regression analysis. Results: The patients were followed up for 3 to 120 months, with an average follow-up time of 34.4 months. All 152 patients completed the planned radiotherapy and chemotherapy cycles. The 2-year and 3-year overall survival (OS) rates for all patients were 86.8% and 74.6%, respectively, and the progression-free survival (PFS) rates were 83.5% and 73.3%, respectively. In the p16+ patients (n=71), the 2-year and 3-year OS rates were 98.9% and 93.2% respectively, and the PFS rates were 97.6% and 91.1% respectively. For p16- patients (n=33), the 2-year and 3-year OS rates were 77.2% and 61.4% respectively, and the PFS rates were 74.6% and 58.5% respectively. The p16+ patients showed the higher OS and PFS than p16- patients (χ2 values were 7.27 and 6.64 respectively, and both P values were <0.05). After treatment, 127 cases (83.3%) developed grade 3 oropharyngeal mucositis, and 7 cases (4.6%) required nasogastric feeding or parenteral nutrition. No patients underwent gastrostomy, and all patients were able to tolerate the adverse reactions. Conclusion: Non-surgical comprehensive therapy (IC+CCRT±EGFR inhibitors) is an effective treatment modality for advanced OPSSC, and patients can generally tolerate the associated adverse reactions. Moreover, p16+ patients exhibit a higher survival rate compared to p16- patients.

目的:探讨局部晚期口咽鳞状细胞癌(OPSCC)非手术综合治疗方法的有效性和安全性,并分析HPV(人乳头瘤病毒)状态对患者预后的影响。方法:回顾性分析2010年10月至2024年10月解放军总医院耳鼻喉头颈外科采用非手术综合治疗方法治疗的晚期OPSCC患者152例。男性114例,女性38例,年龄38 ~ 70岁,中位年龄55.5岁。治疗包括诱导化疗(IC)+同步放化疗(CCRT)±表皮生长因子受体(EGFR)分子靶向治疗,其中126例患者在CCRT期间接受EGFR分子靶向药物治疗(124例使用尼莫单抗+2例使用西妥昔单抗),32例患者在诱导化疗期间接受PD-1免疫治疗。放射治疗采用螺旋断层治疗(HT)和调强放疗(IMRT)技术。使用不良事件通用术语标准(CTCAE)第5版评估放化疗的不良反应。生存率采用Kaplan-Meier法和Cox回归分析。结果:患者随访3 ~ 120个月,平均随访34.4个月。所有152例患者均完成了计划的放疗和化疗周期。所有患者的2年和3年总生存率(OS)分别为86.8%和74.6%,无进展生存率(PFS)分别为83.5%和73.3%。在p16+患者(n=71)中,2年和3年OS分别为98.9%和93.2%,PFS分别为97.6%和91.1%。对于p16-患者(n=33), 2年和3年OS分别为77.2%和61.4%,PFS分别为74.6%和58.5%。结论:非手术综合治疗(IC+CCRT±EGFR抑制剂)是晚期OPSSC的有效治疗方式,且患者可耐受相关不良反应。此外,p16+患者比p16-患者表现出更高的生存率。
{"title":"[Clinical study on induction chemotherapy combined with concurrent chemoradiotherapy for oropharyngeal squamous cell carcinoma].","authors":"J Wei, K Liu, N X Chen, J S Sui, T Sun, L Ma, X X Zhang","doi":"10.3760/cma.j.cn115330-20250123-00069","DOIUrl":"10.3760/cma.j.cn115330-20250123-00069","url":null,"abstract":"<p><p><b>Objective:</b> To investigate the efficacy and safety of non-surgical comprehensive treatment methods for patients with locally advanced oropharyngeal squamous cell carcinoma (OPSCC) and to analyze the impact of HPV (human papilloma virus) status on the patients' prognoses. <b>Methods:</b> A retrospective analysis was conducted on 152 patients with advanced OPSCC treated with non-surgical comprehensive treatment methods at the Department of Otolaryngology Head and Neck Surgery of the PLA General Hospital from October 2010 to October 2024. There were 114 males and 38 females, aged from 38 to 70 years, with a median age of 55.5 years. The treatments included induction chemotherapy (IC)+concurrent chemoradiotherapy (CCRT)±epidermal growth factor receptor (EGFR) molecular targeted therapy, including 126 patients treated with EGFR molecular targeted drugs during CCRT (124 with nimotuzumab+2 with cetuximab) and 32 patients with PD-1 immunotherapy during induction chemotherapy. Helical tomotherapy (HT) and intensity-modulated radiotherapy (IMRT) techniques were used in radiotherapy. The adverse reactions of chemoradiotherapy were assessed using the Common Terminology Criteria for Adverse Events (CTCAE) version 5. survival rates were analyzed using the Kaplan-Meier method and Cox regression analysis. <b>Results:</b> The patients were followed up for 3 to 120 months, with an average follow-up time of 34.4 months. All 152 patients completed the planned radiotherapy and chemotherapy cycles. The 2-year and 3-year overall survival (OS) rates for all patients were 86.8% and 74.6%, respectively, and the progression-free survival (PFS) rates were 83.5% and 73.3%, respectively. In the p16+ patients (<i>n</i>=71), the 2-year and 3-year OS rates were 98.9% and 93.2% respectively, and the PFS rates were 97.6% and 91.1% respectively. For p16- patients (<i>n</i>=33), the 2-year and 3-year OS rates were 77.2% and 61.4% respectively, and the PFS rates were 74.6% and 58.5% respectively. The p16+ patients showed the higher OS and PFS than p16- patients (<i>χ</i><sup>2</sup> values were 7.27 and 6.64 respectively, and both <i>P</i> values were <0.05). After treatment, 127 cases (83.3%) developed grade 3 oropharyngeal mucositis, and 7 cases (4.6%) required nasogastric feeding or parenteral nutrition. No patients underwent gastrostomy, and all patients were able to tolerate the adverse reactions. <b>Conclusion:</b> Non-surgical comprehensive therapy (IC+CCRT±EGFR inhibitors) is an effective treatment modality for advanced OPSSC, and patients can generally tolerate the associated adverse reactions. Moreover, p16+ patients exhibit a higher survival rate compared to p16- patients.</p>","PeriodicalId":23987,"journal":{"name":"Chinese journal of otorhinolaryngology head and neck surgery","volume":"60 ","pages":"1552-1560"},"PeriodicalIF":0.0,"publicationDate":"2025-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145726389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Follicular thyroid carcinoma combined with anaplastic thyroid carcinoma: a report of two cases]. 滤泡性甲状腺癌合并间变性甲状腺癌2例报告
Q4 Medicine Pub Date : 2025-12-07 DOI: 10.3760/cma.j.cn115330-20250426-00255
Q Zhang, M Yang, Y L Wang
{"title":"[Follicular thyroid carcinoma combined with anaplastic thyroid carcinoma: a report of two cases].","authors":"Q Zhang, M Yang, Y L Wang","doi":"10.3760/cma.j.cn115330-20250426-00255","DOIUrl":"10.3760/cma.j.cn115330-20250426-00255","url":null,"abstract":"","PeriodicalId":23987,"journal":{"name":"Chinese journal of otorhinolaryngology head and neck surgery","volume":"60 12","pages":"1602-1603"},"PeriodicalIF":0.0,"publicationDate":"2025-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145811420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The study progress of circulating tumor HPV DNA in HPV-positive oropharyngeal carcinoma]. [HPV阳性口咽癌循环肿瘤HPV DNA研究进展]。
Q4 Medicine Pub Date : 2025-12-07 DOI: 10.3760/cma.j.cn115330-20250103-00007
L Q Xue, Y Guo
{"title":"[The study progress of circulating tumor HPV DNA in HPV-positive oropharyngeal carcinoma].","authors":"L Q Xue, Y Guo","doi":"10.3760/cma.j.cn115330-20250103-00007","DOIUrl":"10.3760/cma.j.cn115330-20250103-00007","url":null,"abstract":"","PeriodicalId":23987,"journal":{"name":"Chinese journal of otorhinolaryngology head and neck surgery","volume":"60 ","pages":"1645-1648"},"PeriodicalIF":0.0,"publicationDate":"2025-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145726357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical characteristics and surgical management of primary intralabyrinthine tumor]. 原发性甲状腺内肿瘤的临床特点及手术治疗
Q4 Medicine Pub Date : 2025-12-07 DOI: 10.3760/cma.j.cn115330-20250311-00139
P C Sun, Z Jiang, L Xu, D G Zhang, M M Wang, Z M Fan, H B Wang, Y C Han
<p><p><b>Objective:</b> To analyze the clinical characteristics of primary intralabyrinthine tumors and to explore effective diagnostic and therapeutic strategies. <b>Methods:</b> A retrospective analysis was conducted on the clinical data of 41 patients with primary intralabyrinthine tumors diagnosed and treated at Shandong Second Provincial General Hospital (Shandong Provincial ENT Hospital) from August 2011 to December 2024. There were 16 males and 25 females, with a mean age of (49.6±11.4) years (mean±standard deviation); 20 cases occurred on the left side and 21 on the right side. All cases were diagnosed by high-resolution magnetic resonance imaging (HR-MRI), and 19 of them underwent surgical treatment, with the diagnosis confirmed by postoperative pathology. Imaging follow-up was performed for the surgical patients, and their clinical symptoms, imaging features, intervention methods, and therapeutic outcomes were summarized and analyzed. <b>Results:</b> Among the 41 patients, the most common symptom was hearing loss (39/41, 95.1%), followed by tinnitus (35/41, 85.4%), vertigo/dizziness (16/41, 39.0%), and ear fullness (15/41, 36.6%). The pure tone average (PTA) at 500, 1 000, 2 000, and 4 000 Hz was (97.1±29.0) dBHL. According to the WHO hearing loss classification, there were 1 case of mild hearing loss, 1 case of moderate hearing loss, 5 cases of moderately severe hearing loss, 5 cases of severe hearing loss, 5 cases of profound hearing loss, and 24 cases of total hearing loss. According to the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) hearing classification, there were 1 case of Class A, 1 case of Class B, 2 cases of Class C, and 37 cases of Class D. Classification by tumor invasion site showed 24 cases of intracochlear type, 8 cases of vestibulocochlear type, 5 cases of transotic type (2 of which invaded the cerebellopontine angle), 3 cases of intravestibular type, and 1 case of transmodiolar type. For treatment modalities, 22 patients opted for follow-up observation, and 19 patients underwent surgical treatment (4 out of 5 transotic patients received staged surgery; 5 patients underwent simultaneous cochlear implantation; and 3 patients underwent tumor resection via the transcanal promontory approach under otoendoscopy). Postoperative pathological results revealed that 18 cases were schwannomas, and 1 case was neurofibroma. The follow-up duration for surgical patients ranged from 6 months to 10 years. Only 1 patient had residual tumor recurrence in the cochlea 3 years after surgery, and achieved complete recovery after reoperation; no recurrence was observed in the other surgical patients. <b>Conclusions:</b> Intralabyrinthine tumors are mainly characterized by hearing loss, most of which are sensorineural hearing loss of severe degree or above. Enhanced thin-slice MRI of the temporal bone is the most valuable imaging examination method. The treatment strategy can be either imaging follow-up or surgical interv
目的:分析原发性甲状腺内肿瘤的临床特点,探讨有效的诊断和治疗策略。方法:回顾性分析2011年8月至2024年12月山东省第二省立总医院(山东省耳鼻喉科医院)诊治的41例原发性甲状腺内肿瘤患者的临床资料。男性16例,女性25例,平均年龄(49.6±11.4)岁(平均值±标准差);左侧20例,右侧21例。所有病例均通过高分辨率磁共振成像(HR-MRI)诊断,其中19例接受手术治疗,术后病理证实诊断。对手术患者进行影像学随访,总结分析其临床症状、影像学特征、干预方法及治疗效果。结果:41例患者中,最常见的症状为听力损失(39/41,95.1%),其次为耳鸣(35/41,85.4%)、眩晕/头晕(16/41,39.0%)、耳胀(15/41,36.6%)。500、1 000、2 000和4 000 Hz时的纯音平均(PTA)为(97.1±29.0)dBHL。根据WHO的听力损失分类,轻度听力损失1例,中度听力损失1例,中重度听力损失5例,重度听力损失5例,深度听力损失5例,完全听力损失24例。据美国头颈外科学院一份子)听力分类,有1例类,B类1例,2例C类,和37例类d .肿瘤入侵网站的分类显示intracochlear类型的24例,蜗型8例,5例transotic类型(2入侵小脑桥脑角),intravestibular型3例,1例transmodiolar类型。在治疗方式上,22例患者选择随访观察,19例患者接受手术治疗(5例跨音患者中4例分期手术,5例同期人工耳蜗植入,3例在耳内镜下经鼻峡口入路行肿瘤切除术)。术后病理结果显示神经鞘瘤18例,神经纤维瘤1例。手术患者随访时间从6个月到10年不等。仅1例患者术后3年耳蜗残余肿瘤复发,再次手术后完全恢复;其余手术患者无复发。结论:耳蜗内瘤以听力损失为主要特征,多为重度及以上感音神经性听力损失。颞骨增强薄层MRI是最有价值的影像学检查方法。治疗策略可以是影像学随访或手术干预。选择手术入路及是否行听力重建应综合考虑肿瘤大小、侵袭部位、对侧耳听力状况、患者需要等因素。
{"title":"[Clinical characteristics and surgical management of primary intralabyrinthine tumor].","authors":"P C Sun, Z Jiang, L Xu, D G Zhang, M M Wang, Z M Fan, H B Wang, Y C Han","doi":"10.3760/cma.j.cn115330-20250311-00139","DOIUrl":"https://doi.org/10.3760/cma.j.cn115330-20250311-00139","url":null,"abstract":"&lt;p&gt;&lt;p&gt;&lt;b&gt;Objective:&lt;/b&gt; To analyze the clinical characteristics of primary intralabyrinthine tumors and to explore effective diagnostic and therapeutic strategies. &lt;b&gt;Methods:&lt;/b&gt; A retrospective analysis was conducted on the clinical data of 41 patients with primary intralabyrinthine tumors diagnosed and treated at Shandong Second Provincial General Hospital (Shandong Provincial ENT Hospital) from August 2011 to December 2024. There were 16 males and 25 females, with a mean age of (49.6±11.4) years (mean±standard deviation); 20 cases occurred on the left side and 21 on the right side. All cases were diagnosed by high-resolution magnetic resonance imaging (HR-MRI), and 19 of them underwent surgical treatment, with the diagnosis confirmed by postoperative pathology. Imaging follow-up was performed for the surgical patients, and their clinical symptoms, imaging features, intervention methods, and therapeutic outcomes were summarized and analyzed. &lt;b&gt;Results:&lt;/b&gt; Among the 41 patients, the most common symptom was hearing loss (39/41, 95.1%), followed by tinnitus (35/41, 85.4%), vertigo/dizziness (16/41, 39.0%), and ear fullness (15/41, 36.6%). The pure tone average (PTA) at 500, 1 000, 2 000, and 4 000 Hz was (97.1±29.0) dBHL. According to the WHO hearing loss classification, there were 1 case of mild hearing loss, 1 case of moderate hearing loss, 5 cases of moderately severe hearing loss, 5 cases of severe hearing loss, 5 cases of profound hearing loss, and 24 cases of total hearing loss. According to the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) hearing classification, there were 1 case of Class A, 1 case of Class B, 2 cases of Class C, and 37 cases of Class D. Classification by tumor invasion site showed 24 cases of intracochlear type, 8 cases of vestibulocochlear type, 5 cases of transotic type (2 of which invaded the cerebellopontine angle), 3 cases of intravestibular type, and 1 case of transmodiolar type. For treatment modalities, 22 patients opted for follow-up observation, and 19 patients underwent surgical treatment (4 out of 5 transotic patients received staged surgery; 5 patients underwent simultaneous cochlear implantation; and 3 patients underwent tumor resection via the transcanal promontory approach under otoendoscopy). Postoperative pathological results revealed that 18 cases were schwannomas, and 1 case was neurofibroma. The follow-up duration for surgical patients ranged from 6 months to 10 years. Only 1 patient had residual tumor recurrence in the cochlea 3 years after surgery, and achieved complete recovery after reoperation; no recurrence was observed in the other surgical patients. &lt;b&gt;Conclusions:&lt;/b&gt; Intralabyrinthine tumors are mainly characterized by hearing loss, most of which are sensorineural hearing loss of severe degree or above. Enhanced thin-slice MRI of the temporal bone is the most valuable imaging examination method. The treatment strategy can be either imaging follow-up or surgical interv","PeriodicalId":23987,"journal":{"name":"Chinese journal of otorhinolaryngology head and neck surgery","volume":"60 12","pages":"1571-1579"},"PeriodicalIF":0.0,"publicationDate":"2025-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145811411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A preliminary comparison of 2-digit and 3-digit digit-in-noise tests in hearing screening]. [听力筛查中2位和3位数字噪声测试的初步比较]。
Q4 Medicine Pub Date : 2025-12-07 DOI: 10.3760/cma.j.cn115330-20250120-00061
X L Shen, S Q G Wang, L N Wong, X Wu, X Wang

Objective: This study aims to preliminarily explore the impact of cognitive function on 2-digit and 3-digit digit-in-noise tests in the Ningbo dialect version, particularly when used for hearing screening. Methods: A total of 31 older native speakers of the Ningbo dialect were selected. The cohort comprised 13 males and 18 females, with an age range of 60 to 88 years and a mean age of 73.6 years. Participants completed pure-tone audiometry, the Ningbo dialect versions of the 2-digit and 3-digit digit-in-noise tests twice, the Chinese version of the Montreal Cognitive Assessment (MoCA-BC) basic scale, and the auditory version of the digit span test. Results: Spearman's correlation analysis showed that MoCA-BC scores were significantly correlated only with the second SRT (speech reception threshold) of the digit triplet test. There was no significant correlation between digit span scores and the results of any of the digit-in-noise tests. Attention scores from the MoCA-BC were significantly correlated with the first (rs=-0.374, P=0.038) and second (rs=-0.369, P=0.041) SRTs of the 3-digit condition but showed no significant correlation with the first and second SRTs of the 2-digit condition. The effectiveness of the 3-digit and 2-digit in hearing screening was found to be generally consistent. When using an average hearing threshold of 35 dB HL in the better ear as the hearing screening cut-off point, ROC curve analysis revealed that the areas under the curve (AUC) for the first and second trials of the 2-digit and the first and second trials of the 3-digit test were 0.868, 0.864, 0.873, and 0.857, respectively. Conclusion: Cognitive function has little effect on the results of 2-digit and 3-digit digit-in-noise tests. However, compared to the 3-digit, the 2-digit is simpler and less affected by cognitive decline.

目的:本研究旨在初步探讨宁波方言版2位和3位数字噪声测试中认知功能的影响,特别是在用于听力筛选时。方法:选取年龄较大、母语为宁波话的人31例。研究对象男性13人,女性18人,年龄60 ~ 88岁,平均年龄73.6岁。参与者分别完成纯音听力测试、宁波方言版2位数和3位数噪声测试、中文版蒙特利尔认知评估(MoCA-BC)基本量表和听觉版数字广度测试。结果:Spearman相关分析显示,MoCA-BC得分仅与数字三连字测试的第二次SRT(语音接收阈值)显著相关。数字广度得分与任何数字噪声测试的结果之间没有显著的相关性。MoCA-BC的注意得分与3位数组的第一、第二srt (rs=-0.374, P=0.038)、第二srt (rs=-0.369, P=0.041)显著相关,与2位数组的第一、第二srt无显著相关。3指和2指在听力筛查中的效果基本一致。以较好耳35 dB HL的平均听力阈值作为听力筛选的截断点,ROC曲线分析显示,2指试验一、二次试验和3指试验一、二次试验的曲线下面积(AUC)分别为0.868、0.864、0.873和0.857。结论:认知功能对2位和3位数字噪声测试结果影响不大。然而,与3位数相比,2位数更简单,受认知能力下降的影响也更小。
{"title":"[A preliminary comparison of 2-digit and 3-digit digit-in-noise tests in hearing screening].","authors":"X L Shen, S Q G Wang, L N Wong, X Wu, X Wang","doi":"10.3760/cma.j.cn115330-20250120-00061","DOIUrl":"https://doi.org/10.3760/cma.j.cn115330-20250120-00061","url":null,"abstract":"<p><p><b>Objective:</b> This study aims to preliminarily explore the impact of cognitive function on 2-digit and 3-digit digit-in-noise tests in the Ningbo dialect version, particularly when used for hearing screening. <b>Methods:</b> A total of 31 older native speakers of the Ningbo dialect were selected. The cohort comprised 13 males and 18 females, with an age range of 60 to 88 years and a mean age of 73.6 years. Participants completed pure-tone audiometry, the Ningbo dialect versions of the 2-digit and 3-digit digit-in-noise tests twice, the Chinese version of the Montreal Cognitive Assessment (MoCA-BC) basic scale, and the auditory version of the digit span test. <b>Results:</b> Spearman's correlation analysis showed that MoCA-BC scores were significantly correlated only with the second SRT (speech reception threshold) of the digit triplet test. There was no significant correlation between digit span scores and the results of any of the digit-in-noise tests. Attention scores from the MoCA-BC were significantly correlated with the first (<i>rs</i>=-0.374, <i>P</i>=0.038) and second (<i>rs</i>=-0.369, <i>P</i>=0.041) SRTs of the 3-digit condition but showed no significant correlation with the first and second SRTs of the 2-digit condition. The effectiveness of the 3-digit and 2-digit in hearing screening was found to be generally consistent. When using an average hearing threshold of 35 dB HL in the better ear as the hearing screening cut-off point, ROC curve analysis revealed that the areas under the curve (AUC) for the first and second trials of the 2-digit and the first and second trials of the 3-digit test were 0.868, 0.864, 0.873, and 0.857, respectively. <b>Conclusion:</b> Cognitive function has little effect on the results of 2-digit and 3-digit digit-in-noise tests. However, compared to the 3-digit, the 2-digit is simpler and less affected by cognitive decline.</p>","PeriodicalId":23987,"journal":{"name":"Chinese journal of otorhinolaryngology head and neck surgery","volume":"60 12","pages":"1586-1592"},"PeriodicalIF":0.0,"publicationDate":"2025-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145811456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis of the correlation between inflammatory parameters and clinical characteristics in oropharyngeal cancer patients]. 口咽癌患者炎症参数与临床特征的相关性分析
Q4 Medicine Pub Date : 2025-12-07 DOI: 10.3760/cma.j.cn115330-20251023-00557
L Zhang, S X Wen, J Wang, Z L Li, R Wang, C Wang

Objective: To investigate the clinical characteristics of patients with oropharyngeal squamous cell carcinoma (OPSCC) and the relationship between the clinical characteristics and pre-treatment inflammatory parameters such as neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), systemic inflammation response index (SII), and systemic inflammation response index (SIRI). Methods: A retrospective analysis was conducted on the clinical data of 149 OPSCC patients treated in two tertiary hospitals, Shanxi Province Cancer Hospital and Shanxi Bethune Hospital, between January 2017 and January 2024, including 129 males and 20 females, aged from 37 to 84 years old. The patients were grouped based on HPV infection status (p16 expression), namely p16-positive group and p16-negative group, and statistical analysis was performed to evaluate the correlation between the inflammatory parameters and clinical factors such as clinical stage, treatment regimen, and prognosis in two groups. Statistical analysis was conducted using SPSS 29.0 software. Results: In this cohort, 56.4%(84/149) of OPSCC patients were p16-positive. The total 1-year and 3-year survival rates were 87.0% and 66.5%, respectively. Analysis showed p16 status was an independent prognostic factor (HR=0.444, 95%CI: 0.206-0.957, P=0.038). No significant difference in prognosis was observed between p16-positive and p16-negative groups when NLR, PLR, and SII levels were elevated (all P>0.05). Pre-treatment SII levels were significantly higher in p16-positive patients compared to p16-negative patients (62.4% vs. 37.6%, χ2=8.021, P=0.005). Elevated pre-treatment PLR levels indicated a higher risk of lymph node metastasis (χ2=4.791, P=0.029). Conclusion: Elevated levels of NLR, PLR, and SII may attenuate the prognostic advantage of HPV-positive OPSCC. SII and PLR may play important roles in predicting HPV infection status and the risk of cervical lymph node metastasis in OPSCC patients.

目的:探讨口咽鳞状细胞癌(OPSCC)患者的临床特征及其与治疗前炎症参数如中性粒细胞与淋巴细胞比值(NLR)、单核细胞与淋巴细胞比值(MLR)、血小板与淋巴细胞比值(PLR)、全身炎症反应指数(SII)、全身炎症反应指数(SIRI)的关系。方法:回顾性分析2017年1月至2024年1月在山西省肿瘤医院和山西省白求恩医院两所三级医院收治的149例OPSCC患者的临床资料,其中男性129例,女性20例,年龄37 ~ 84岁。根据患者HPV感染状态(p16表达)进行分组,分为p16阳性组和p16阴性组,统计分析两组患者炎症参数与临床分期、治疗方案、预后等临床因素的相关性。采用SPSS 29.0软件进行统计学分析。结果:在该队列中,56.4%(84/149)的OPSCC患者p16阳性。1年和3年总生存率分别为87.0%和66.5%。分析显示p16状态是独立的预后因素(HR=0.444, 95%CI: 0.206 ~ 0.957, P=0.038)。NLR、PLR、SII水平升高时,p16阳性组与p16阴性组预后无显著差异(P < 0.05)。p16阳性患者治疗前SII水平明显高于p16阴性患者(62.4%比37.6%,χ2=8.021, P=0.005)。治疗前PLR水平升高提示淋巴结转移风险增高(χ2=4.791, P=0.029)。结论:NLR、PLR和SII水平升高可能会降低hpv阳性OPSCC的预后优势。SII和PLR可能在预测OPSCC患者HPV感染状态和颈部淋巴结转移风险方面发挥重要作用。
{"title":"[Analysis of the correlation between inflammatory parameters and clinical characteristics in oropharyngeal cancer patients].","authors":"L Zhang, S X Wen, J Wang, Z L Li, R Wang, C Wang","doi":"10.3760/cma.j.cn115330-20251023-00557","DOIUrl":"10.3760/cma.j.cn115330-20251023-00557","url":null,"abstract":"<p><p><b>Objective:</b> To investigate the clinical characteristics of patients with oropharyngeal squamous cell carcinoma (OPSCC) and the relationship between the clinical characteristics and pre-treatment inflammatory parameters such as neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), systemic inflammation response index (SII), and systemic inflammation response index (SIRI). <b>Methods:</b> A retrospective analysis was conducted on the clinical data of 149 OPSCC patients treated in two tertiary hospitals, Shanxi Province Cancer Hospital and Shanxi Bethune Hospital, between January 2017 and January 2024, including 129 males and 20 females, aged from 37 to 84 years old. The patients were grouped based on HPV infection status (p16 expression), namely p16-positive group and p16-negative group, and statistical analysis was performed to evaluate the correlation between the inflammatory parameters and clinical factors such as clinical stage, treatment regimen, and prognosis in two groups. Statistical analysis was conducted using SPSS 29.0 software. <b>Results:</b> In this cohort, 56.4%(84/149) of OPSCC patients were p16-positive. The total 1-year and 3-year survival rates were 87.0% and 66.5%, respectively. Analysis showed p16 status was an independent prognostic factor (<i>HR</i>=0.444, 95%<i>CI:</i> 0.206-0.957, <i>P</i>=0.038). No significant difference in prognosis was observed between p16-positive and p16-negative groups when NLR, PLR, and SII levels were elevated (all <i>P</i>>0.05). Pre-treatment SII levels were significantly higher in p16-positive patients compared to p16-negative patients (62.4% <i>vs.</i> 37.6%, <i>χ</i><sup>2</sup>=8.021, <i>P</i>=0.005). Elevated pre-treatment PLR levels indicated a higher risk of lymph node metastasis (<i>χ</i><sup>2</sup>=4.791, <i>P</i>=0.029). <b>Conclusion:</b> Elevated levels of NLR, PLR, and SII may attenuate the prognostic advantage of HPV-positive OPSCC. SII and PLR may play important roles in predicting HPV infection status and the risk of cervical lymph node metastasis in OPSCC patients.</p>","PeriodicalId":23987,"journal":{"name":"Chinese journal of otorhinolaryngology head and neck surgery","volume":"60 ","pages":"1561-1570"},"PeriodicalIF":0.0,"publicationDate":"2025-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145726302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Application of artificial intelligence technology in pollen monitoring]. 人工智能技术在花粉监测中的应用
Q4 Medicine Pub Date : 2025-12-07 DOI: 10.3760/cma.j.cn115330-20250701-00348
G X Liang, X Luo, X K Huang, Q T Yang
{"title":"[Application of artificial intelligence technology in pollen monitoring].","authors":"G X Liang, X Luo, X K Huang, Q T Yang","doi":"10.3760/cma.j.cn115330-20250701-00348","DOIUrl":"10.3760/cma.j.cn115330-20250701-00348","url":null,"abstract":"","PeriodicalId":23987,"journal":{"name":"Chinese journal of otorhinolaryngology head and neck surgery","volume":"60 ","pages":"1610-1615"},"PeriodicalIF":0.0,"publicationDate":"2025-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145726351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Chinese journal of otorhinolaryngology head and neck surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1